Don't miss

Replay


LATEST SHOWS

FASHION

Paris Men's Fall/Winter 2015, freedom of speech triumphs

Read more

BUSINESS DAILY

Davos 2015: Businesses 'cautiously optimistic' in Japan

Read more

MEDIAWATCH

Twitter storm as IMF boss Christine Lagarde hails Saudi King Abdullah as 'strong advocate of women'

Read more

EYE ON AFRICA

DR CONGO: Senate amends controversial constitutional law

Read more

THE WORLD THIS WEEK

Pope Family Planning: Heated Debate over Pontiff's 'Rabbit' Comments (part 2)

Read more

THE WORLD THIS WEEK

Saudi King Abdullah Dies: Succession, Stability and Youth in Question (part 1)

Read more

FRANCE IN FOCUS

France tackles terror

Read more

THE BUSINESS INTERVIEW

Jean-Pascal Tricoire, CEO of Schneider Electric: 'France is on a better track'

Read more

DEBATE

Davos debate: Can big business agree on climate deal? (part 2)

Read more

Sanofi-Aventis withdraws anti-obesity drug from European shelves

Text by AFP

Latest update : 2008-10-24

EU authorities have suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent, due to an abnormal risk of psychiatric problems.

EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.

"Sales have been halted in all the pharmacies in the 18 countries of the European Union where it is distributed," a company spokesman told AFP.

Sanofi-Aventis said the European Medicines Agency (EMEA) had warned that patients taking the drug ran almost double the normal risk of psychiatric problems.

"The risks of taking Acomplia are now greater than the benefits that the drug can bring the patient according to its current guidelines," the company said, citing the EMEA.

Europe has allowed sales of Acomplia since 2006, but it has not been authorised in the United States where authorities believe it encourages suicidal thoughts, even in patients with no history of depression.

The company said it had not ruled out withdrawing the drug in the 14 non-EU countries where it is sold. It said users of the drug should consult a doctor or pharmacist.
 

Date created : 2008-10-24

COMMENT(S)